Xoloninvest
VC Fund
Seoul, South Korea
Xoloninvest is a VC fund in Seoul focused on EdTech and Medical. Xoloninvest is engaged in investment in early-stage companies, listing, and unlisted mezzanine investment.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Xoloninvest invests in
Stages Xoloninvest invests in
Countries Xoloninvest invests in
Investment Focus
Industry
- EdTech 1 (20%)
- Medical 1 (20%)
- Printing 1 (20%)
- Software 1 (20%)
- Tutoring 1 (20%)
Stage
- Series A 2 (40%)
- Series B 1 (20%)
- Series C 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- South Korea 4 (80%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NEUROPHET
|
Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. | $15.3M / Series C / Nov 07, 2023 | |
TILON
|
Tilon provides cloud-based virtualization solutions and appliances products, including patented technology, to various customers such as government offices, finance, medical care, education, manufacturing, and national defense. Their setting cloud smart workspace and digital asset management as their main business areas, they are expanding theirbusiness portfolio such as smart message/DM and advancement of the electronic document distribution systems by integrating blockchain-based electronic document processing technology with virtualization solutions. | $4.1M / Venture - Series Unknown / Mar 22, 2022 | |
Ringle
|
Ringle is a premium 1:1 online English learning platform that connects top tutors with global employees looking to perfect their English | $17.7M / Series A / Mar 31, 2021 | |
Rebus Biosystems
|
Rebus Biosystems is a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise. The company’s first instrument, the Rebus Esper, is a fully integrated, automated spatial omics platform that delivers quantitative single molecule, single-cell data withsubcellular resolution. Advanced imaging, on-system chemistry, and intuitive software have been combined to provide an end-to-end solution requiring minimal hands-on time. Rebus Biosystems provides all-inclusive assay kits to empower researchers with the resolution, scale and speed of the Rebus Esper for multiple applications. Learn more at www.rebusbio.com. | $20M / Series B / Nov 19, 2020 | |
Marpple
|
Marpple offers products with creative content and prints such as custom t-shirts, mobile covers and cups. | $1.9M / Series A / Jun 09, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Xoloninvest invest in?
Xoloninvest invests primarily in EdTech, Medical and Printing startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Xoloninvest last invest?
The most recent investment recorded for Xoloninvest closed in Nov 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
